← Open Payments lookup

KATIE CAMPOS: Open Payments

NPI 1841795804 · MOSCOW, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$473 in 18 payments from 6 companies in 2025. Trend: 2023 $498 · 2024 $352 · 2025 $473

Food & beverage: $473
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$261
Novo Nordisk Inc3$71
Astellas Pharma US Inc2$63
Medtronic, Inc.2$42
Xeris Pharmaceuticals, Inc.1$20
Lilly USA, LLC1$16

Products named: AIRSUPRA, Rybelsus, Veozah, FARXIGA, MINIMED 780G, GVOKE HYPOPEN, INCEPTIV, BREZTRI.

Industry payments across ID — which companies pay providers there.